Glucose Homeostasis in Newborns: An Endocrinology Perspective

Emir Tas1, Luigi Garibaldi2, Radhika Muzumdar2

  • 1Division of Endocrinology and Diabetes, Department of Pediatrics, Arkansas Children's Hospital, Little Rock, AR.

Neoreviews
|January 3, 2020
PubMed

Insights

Neonatal glucose homeostasis relies on postnatal adaptations and feeding. Maintaining normal blood glucose levels is crucial for preventing neurodevelopmental issues in newborns.

Area of Science:

  • Neonatal physiology and endocrinology
  • Pediatric metabolic disorders

Background:

  • Plasma glucose regulation in newborns is complex, influenced by physiological changes and enteral feeding.
  • Defining normal neonatal glucose ranges lacks definitive clinical correlation, leading to ongoing debate.
  • Consensus exists on the importance of maintaining glucose within age-appropriate ranges to prevent adverse neurodevelopmental outcomes.

Purpose of the Study:

  • To review the physiological mechanisms governing glucose homeostasis in newborns.
  • To discuss the diagnostic and management approaches for neonates with disordered glucose metabolism.
  • To emphasize the endocrine underpinnings of abnormal glucose regulation in the neonatal period.

Main Methods:

  • Review of physiological processes involved in maintaining neonatal plasma glucose.
  • Discussion of clinical approaches to managing abnormal glucose levels in newborns.
  • Emphasis on the endocrine factors contributing to glucose dysregulation.

Main Results:

  • Physiological adaptations and enteral feeding are key to maintaining neonatal glucose levels.
  • Management strategies for neonatal hyperglycemia and hypoglycemia are etiology-dependent.
  • Interventions range from nutritional support to medications, hormone therapy, and surgery.

Conclusions:

  • Maintaining appropriate plasma glucose levels in neonates is vital for preventing short- and long-term neurodevelopmental consequences.
  • Understanding the endocrine basis of glucose homeostasis is critical for effective management of neonatal glucose abnormalities.
  • A tailored approach considering the underlying cause is essential for managing disordered glucose homeostasis in newborns.

Related Concept Videos

Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
3.6K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.0K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.0K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
743
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
6.2K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.0K